Toyota Industries Corporation Announces Extension Of Cash Tender Offer For Shares Of Cascade Corporation

Toyota Industries Corporation (Tokyo Stock Exchange: 6201) (“TICO”) today announced that Industrial Components and Attachments II, Inc., an indirect wholly owned subsidiary of TICO, has extended its tender offer for all outstanding common shares of Cascade Corporation (NYSE: CASC) (“Cascade”) for $65.00 per share (the “Offer”). The Offer was scheduled to expire at 12:00 midnight, New York City time, on Thursday, March 21, 2013. With the consent of Cascade, the Offer has been extended to expire at 12:00 midnight, New York City time, on Wednesday, March 27, 2013, unless further extended. All other terms and conditions of the Offer remain unchanged.

As previously announced, TICO received a Request for Additional Information and Documentary Material (the “Second Request”) from the Antitrust Division of the Department of Justice (the “Antitrust Division”) with respect to the Offer. On February 15, 2013, TICO certified to the Antitrust Division substantial compliance with the Second Request. Additionally, TICO provided a timing commitment to the Antitrust Division pursuant to which TICO committed not to close the transaction prior to 30 days thereafter without the consent of the Antitrust Division and to provide at least 10 days notice to the Antitrust Division prior to consummating the acquisition of Cascade. On March 4, 2013, TICO provided a revised timing commitment to the Antitrust Division pursuant to which TICO committed to extend the date prior to which TICO will not consummate the transaction without the consent of the Antitrust Division to 40 days after February 15, 2013 and to provide at least 10 days notice to the Antitrust Division prior to consummating the acquisition of Cascade. Cascade informed TICO that it also received a Request for Additional Information and Documentary Material from the Antitrust Division and that it is currently in the process of responding to such request and intends to cooperate with the Antitrust Division with respect to such request. TICO expects to continue to work cooperatively with the Antitrust Division as it completes its review of the proposed transaction in order to respond to and resolve expeditiously any questions the Antitrust Division may have. The Offer is now scheduled to expire at 12:00 midnight, New York City time, on Wednesday, March 27, 2013. The transaction is expected to be completed immediately upon receiving regulatory approval from the Antitrust Division.

If you liked this article you might like

Cascadian Therapeutics Enlarges Breast Cancer Pill Study to Meet FDA Registration Standards

7 Stocks Under $10 Making Big Moves Higher

6 Stocks that Seth Klarman Loves

Biotech Stock Mailbag: Cascadian Therapeutics, Global Blood Therapeutics, Bad Favus

Stocks Race to Positive Finish